CY1115829T1 - 3,5-Disubstituted and 3,5,7-Trisubstituted-3H-oxazolo Compounds [4,5-d] PYRIMIDIN-2-ONE AND THEIR PRODUCTS - Google Patents

3,5-Disubstituted and 3,5,7-Trisubstituted-3H-oxazolo Compounds [4,5-d] PYRIMIDIN-2-ONE AND THEIR PRODUCTS

Info

Publication number
CY1115829T1
CY1115829T1 CY20141101029T CY141101029T CY1115829T1 CY 1115829 T1 CY1115829 T1 CY 1115829T1 CY 20141101029 T CY20141101029 T CY 20141101029T CY 141101029 T CY141101029 T CY 141101029T CY 1115829 T1 CY1115829 T1 CY 1115829T1
Authority
CY
Cyprus
Prior art keywords
trisubstituted
pyrimidin
disubstituted
products
oxazolo compounds
Prior art date
Application number
CY20141101029T
Other languages
Greek (el)
Inventor
Stephen E Webber
Gregory J Haley
Joseph R Lennox
Alan Xin Xiang
Erik J Rueden
Original Assignee
Anadys Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP12193759.3A external-priority patent/EP2561872B1/en
Application filed by Anadys Pharmaceuticals, Inc. filed Critical Anadys Pharmaceuticals, Inc.
Publication of CY1115829T1 publication Critical patent/CY1115829T1/en

Links

Landscapes

  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Η παρούσα αίτηση αφορά σε μια ένωση που επιλέγεται από ή ένα φαρμακευτικώς αποδεκτό άλας αυτής. Η αίτηση επίσης αφορά σε φαρμακευτικές χρήσεις της ένωσης ή ενός φαρμακευτικώς αποδεκτού άλατος αυτής.The present application relates to a compound selected from or a pharmaceutically acceptable salt thereof. The application also relates to medicinal uses of the compound or a pharmaceutically acceptable salt thereof.

CY20141101029T 2004-12-17 2014-12-10 3,5-Disubstituted and 3,5,7-Trisubstituted-3H-oxazolo Compounds [4,5-d] PYRIMIDIN-2-ONE AND THEIR PRODUCTS CY1115829T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63663304A 2004-12-17 2004-12-17
US63663404A 2004-12-17 2004-12-17
EP12193759.3A EP2561872B1 (en) 2004-12-17 2005-12-16 3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF

Publications (1)

Publication Number Publication Date
CY1115829T1 true CY1115829T1 (en) 2017-01-25

Family

ID=58457070

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20141100315T CY1115050T1 (en) 2004-12-17 2014-05-02 Compounds of 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazole and 3H-thiazolo [4,5- (D) Pyrimidin-2-one and prodrug
CY20141101029T CY1115829T1 (en) 2004-12-17 2014-12-10 3,5-Disubstituted and 3,5,7-Trisubstituted-3H-oxazolo Compounds [4,5-d] PYRIMIDIN-2-ONE AND THEIR PRODUCTS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20141100315T CY1115050T1 (en) 2004-12-17 2014-05-02 Compounds of 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazole and 3H-thiazolo [4,5- (D) Pyrimidin-2-one and prodrug

Country Status (1)

Country Link
CY (2) CY1115050T1 (en)

Also Published As

Publication number Publication date
CY1115050T1 (en) 2016-12-14

Similar Documents

Publication Publication Date Title
CY1106386T1 (en) SUBSTITUTED 3-PYRROLIDINE-INDOLE DERIVATIVES
CY1119381T1 (en) 2-Methylmorpholine Pyridine-, Pyrazo- and Pyrimidine Pyrimidine Derivatives as MTOR Suspensions
CY1114616T1 (en) CYCLOEXANE SPIRACYCLICAL PRODUCTS
CY1108067T1 (en) Substituted 2-Pyridine-Cyclohexane-1,4-Diamine Derivatives
CY1106801T1 (en) NEW HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE AS DRUGS, PARTICULARLY AS ANTI-BACTERIALS
CY1117470T1 (en) SOLID DOSAGE PREPARATIONS WITH IMPROVED ANIMAL ADJUSTMENT
BRPI0417717A (en) compound, pharmaceutical composition, and use of a compound
DE602004027936D1 (en) TOCOPHEROL-MODIFIED THERAPEUTIC DRUG COMPOUND
CY1111797T1 (en) LOCAL PHARMACEUTICAL FORM FOR IVERMECTIN FOR DERMATOLOGICAL TREATMENT
CY1106679T1 (en) AZADICYCLIC HETEROCYCLIC COMPOUNDS AS CANNABINOID RECEPTOR MODIFIERS
CY1109880T1 (en) CaSR COMPONENT
CY1105387T1 (en) SUBSTITUTED 2-DIALKYLAMINOALKYLBIFINTHIUM DERIVATIVES
CY1112376T1 (en) 2,3,4,9-tetrahydro-1H-carvasol derivative as CRTH2 receptor antagonists
CY1110258T1 (en) Substituted C-cyclohexylmethylamine derivatives
EA200701181A1 (en) MEDICINES INTENDED FOR THE TREATMENT OR PREVENTION OF FIBROUS DISEASES
SE0401342D0 (en) Therapeutic compounds
CY1105028T1 (en) SUBSTITUTED C-IMIDAZO-[1,2-A]PYRIDIN-3-YL-METHYLAMINES
ATE466842T1 (en) 3-SUBSTITUTED PYRIDINE DERIVATIVES AS H3 ANTAGONISTS
CY1112173T1 (en) THE USE OF CILOBRADINE OR THESE PHARMACEUTICAL SALVES FOR THE TREATMENT OR PREVENTION OF HEART DEFICIENCY
CY1110913T1 (en) 2-PYRROLIDIN-2-YlO- [1,3,4] -OXADIASOL PRODUCTION AND THEIR USE AS ANTI-ANTI-ANTICIPATES
CY1105019T1 (en) SUBSTITUTED C-IMIDAZO-[1,2-A]PYRIDIN-3-YL-METHYLAMINES
CY1115955T1 (en) A STRONG PHARMACEUTICAL FORM
EA200602154A1 (en) PYRIDIN-4-ILEETINILIMIDAZOLES AND -PYRAZOLES AS ANTAGONISTS OF MGLU5 RECEPTOR
CY1105142T1 (en) USE OF 6-DIMETHYLAMINOMETHYL-1-PHENYL-CYCLOHEXANE SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF URINARY INCONTINENCE
DE60112960D1 (en) CONDENSED PYRIDOINDOL DERIVATIVES